Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Pembangunan Jaya Ancol Tbk. (PJAA) Price & Performance

Indofarma Tbk.Trade
Pembangunan Jaya Ancol Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Pembangunan Jaya Ancol Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Pembangunan Jaya Ancol Tbk. trades at Rp470 (market cap 748.8B, 195.5K 24h volume). The key difference: Pembangunan Jaya Ancol Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFPJAA
Market Cap
390.51B748.8B
Volume
195.5K
Lot
1.96K
Turnover
90.23M
Average Price
461.54
Value
90.23M
Indicative Equilibrium Price
464
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
PJAA
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Pembangunan Jaya Ancol Tbk.

PT Pembangunan Jaya Ancol (Company) was established base on notarial deed No. 33 of Achmad Abid SH, dated July 10, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 13 of Mrs. Aulia Taufani, S.H., dated April 01, 2004.

Read more on PJAA